Atipamezole - CAS 104054-27-5
Catalog number:
104054-27-5
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C14H16N2
Molecular Weight:
212.29
COA:
Inquire
Targets:
Adrenergic Receptor
Description:
Atipamezole, a 4-substituted imidazole derivative, is an alpha2-adrenoceptor blocker which could be used for animals to recover from the anesthesia by lowering blood pressure and increasing heart rate and breathing rate.
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
Off-white to light yellow crystal powder
Synonyms:
atipamezole;4-(2-Ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole;4-(2-Ethyl-2-indanyl)imidazole;MPV-1248
Solubility:
DMSO: ≥ 30 mg/mL
Storage:
-20ºC Freeze
MSDS:
Inquire
Application:
Atipamezole is an alpha2-adrenoceptor blocker which could be used for animals to recover from the anesthesia by lowering blood pressure and increasing heart rate and breathing rate.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Grams-Kilos
Boiling Point:
367.1ºC at 760 mmHg
Density:
1.115 g/cm3
InChIKey:
HSWPZIDYAHLZDD-UHFFFAOYSA-N
InChI:
InChI=1S/C14H16N2/c1-2-14(13-9-15-10-16-13)7-11-5-3-4-6-12(11)8-14/h3-6,9-10H,2,7-8H2,1H3,(H,15,16)
Canonical SMILES:
CCC1(CC2=CC=CC=C2C1)C3=CN=CN3
1.Blood biochemical changes in mice after administration of a mixture of three anesthetic agents.
Ochiai Y1, Iwano H, Sakamoto T, Hirabayashi M, Kaneko E, Watanabe T, Yamashita K, Yokota H. J Vet Med Sci. 2016 Feb 19. [Epub ahead of print]
Currently, from the viewpoint of animal welfare, anesthesia or analgesia is required during experimental procedures in animals that are likely to cause pain. A part of these anesthetics have been reported to influence a blood biochemical level. It is important for us to understand the effect of the anesthetic on blood biochemistry when we choose the anesthetic agent to be used in experiments. In this study, we examined the blood biochemical changes in mice after administration of a new mixture of three anesthetic agents - medetomidine / midazolam / butorphanol (MMB). We subcutaneously administered two dose combinations of MMB (0.45 / 6 / 7.5 and 0.9 / 12 / 15 mg/kg) in mice, followed by administration of atipamezole, for reversal of anesthetic effects, after 1 hr. Thereafter, blood biochemistry was assessed at 1, 4 and 24 hr after MMB administration. We observed that MMB administration caused a transient increase in blood sugar, inorganic phosphorus, potassium and creatine kinase levels.
2.Dexmedetomidine Postconditioning Reduces Brain Injury after Brain Hypoxia-Ischemia in Neonatal Rats.
Ren X1,2, Ma H3, Zuo Z4. J Neuroimmune Pharmacol. 2016 Mar 2. [Epub ahead of print]
Perinatal asphyxia can lead to death and severe disability. Brain hypoxia-ischemia (HI) injury is the major pathophysiology contributing to death and severe disability after perinatal asphyxia. Here, seven-day old Sprague-Dawley rats were subjected to left brain HI. Dexmedetomidine was given intraperitoneally after the brain HI. Yohimbine or atipamezole, two α2 adrenergic receptor antagonists, were given 10 min before the dexmedetomidine injection. Neurological outcome was evaluated 7 or 28 days after the brain HI. Frontal cerebral cortex was harvested 6 h after the brain HI. Left brain HI reduced the left cerebral hemisphere weight assessed 7 days after the brain HI. This brain tissue loss was dose-dependently attenuated by dexmedetomidine. Dexmedetomidine applied within 1 h after the brain HI produced this effect. Dexmedetomidine attenuated the brain HI-induced brain tissue and cell loss as well as neurological and cognitive dysfunction assessed from 28 days after the brain HI.
3.EFFICACY AND SAFETY OF A MEDETOMIDINE-AZAPERONE-ALFAXALONE COMBINATION IN CAPTIVE WHITE-TAILED DEER (ODOCOILEUS VIRGINIANUS).
Pon K, Caulkett N, Woodbury M. J Zoo Wildl Med. 2016 Mar;47(1):29-37. doi: 10.1638/2015-0121.1.
Alfaxalone is a neurosteroid that interacts with gamma-aminobutyric type A receptors to produce central nervous system depression and muscle relaxation. The effects of alfaxalone vary from sedation to general anesthesia. Alfaxalone is synergistic with other tranquilizers and sedatives and therefore has the potential to improve existing alpha-2 adrenergic agonist-based combinations used for wildlife immobilization. The objective of this study was to determine the efficacy and cardiopulmonary effects of a medetomidine-azaperone-alfaxalone (MAA) combination in captive white-tailed deer (Odocoileus virginianus). Eight captive white-tailed deer were restrained in a drop-floor chute; hand injected i.m. with 0.15 mg/kg medetomidine, 0.2 mg/kg azaperone, and 0.5 mg/kg alfaxalone; and released into a small enclosure for observation. The deer were maintained in lateral recumbency for a total time from postinjection (PI) of the drug of 60 min. At 60 min PI, atipamezole was administered i.
4.The adrenergic α2 antagonist atipamezole alters the behavioural effects of pramipexole and increases pramipexole concentration in blood plasma.
McCormick PN1, Fletcher PJ2, Wilson VS3, Remington GJ4. Life Sci. 2016 Mar 11. pii: S0024-3205(16)30165-5. doi: 10.1016/j.lfs.2016.03.017. [Epub ahead of print]
Pramipexole is a dopaminergic agonist used in Parkinson's disease treatment. It is thought to exert its therapeutic and side effects through actions on dopamine D3 receptors. In a recent study, we found that at doses occupying D3 but not D2 receptors pramipexole reduced locomotion and operant responding for primary and conditioned reinforcement. These effects, however, were not blocked by a D3 receptor antagonist and were present in D3 knockout mice, suggesting non-D3 receptor mechanisms. Among the next highest affinity binding sites of pramipexole are adrenergic α2 receptors. Here we explored α2 receptor involvement in the behavioural effects of pramipexole. We found that the α2 antagonist atipamezole, which was itself behaviourally silent, counteracted pramipexole's reduction of locomotion, but not operant responding for water or a conditioned reinforcer. The resulting behavioural profile was similar to that of a higher dose of pramipexole, leading to the hypothesize that atipamezole mediates its behavioural effects by increasing pramipexole effective dose.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adrenergic Receptor Products


CAS 18559-94-9 Salbutamol

Salbutamol
(CAS: 18559-94-9)

Salbutamol is a short-acting agonist that specifically targets β2-adrenergic receptor to alleviate bronchospasm in conditions such as asthma and chronic obstruc...

Dobutamine HCl
(CAS: 49745-95-1)

Dobutamine is a sympathomimetic drug used in the treatment of heart failure and cardiogenic shock. Its primary mechanism is direct stimulation of β1 receptors o...

CAS 138908-40-4 CL-316243 sodium

CL-316243 sodium
(CAS: 138908-40-4)

CL-316243 is a highly selective β3-adrenoceptor agonist with EC50 value of 3 nM; > 10000-fold selective over β1 and β2 receptors. CL-316243 can restore the expr...

CAS 13655-52-2 Alprenolol

Alprenolol
(CAS: 13655-52-2)

Alprenolol is a non-selective Beta-Adrenergic receptor and 5-HT1A receptor antagonist for the treatment of angina pectoris.

CAS 36085-73-1 B-HT 920 dihydrochloride

B-HT 920 dihydrochloride
(CAS: 36085-73-1)

Talipexole is a D2 dopamine receptor agonist, displaying anti-Parkinsonian activity.

CAS 829-74-3 Levonordefrin

Levonordefrin
(CAS: 829-74-3)

Levonordefrin is a adrenergic receptor agonist and can be used as a topical nasal decongestant and vasoconstrictor in dentistry in the United States. Levonordef...

Guanfacine Hydrochloride
(CAS: 249-443-3)

Guanfacine Hydrochloride is a centrally acting alpha-2 adrenergic agonist that has been available as an FDA-approved hypotensive agent for more than two decades...

CAS 65023-16-7 Bometolol Hydrochloride

Bometolol Hydrochloride
(CAS: 65023-16-7)

Bometolol is a beta-adrenergic blocking drug.

CAS 81403-80-7 Alfuzosin

Alfuzosin
(CAS: 81403-80-7)

Alfuzosin is a pharmaceutical drug of the alpha-1 blocker class. It works by relaxing the muscles in the prostate and bladder neck. It is used to treat benign p...

CAS 43229-80-7 Formoterol Hemifumarate

Formoterol Hemifumarate
(CAS: 43229-80-7)

Formoterol Hemifumarate is a potent, selective and long-acting β2-adrenoceptor agonist to β2 and β1 receptors with pKd of 8.12 and 5.58, respectively.

CAS 57149-07-2 Naftopidil

Naftopidil
(CAS: 57149-07-2)

Naftopidil is a selective α1-adrenergic receptor antagonist or alpha blocker with a Ki of 58.3 nM.

CAS 106463-17-6 Tamsulosin HCl

Tamsulosin HCl
(CAS: 106463-17-6)

The hydrochloride salt form of Tamsulosin which could block on the sympathetic α1 receptor, especially selectively bind to the α1A receptor so that has been fou...

CAS 5985-28-4 Synephrine Hydrochloride

Synephrine Hydrochloride
(CAS: 5985-28-4)

SynephrineHCl (Oxedrine, p-Synephrine) is a sympathomimetic α-adrenergic receptor (AR) agonist.

CAS 65576-45-6 Asenapine

Asenapine
(CAS: 65576-45-6)

Asenapine is an atypical antipsychotic multireceptor neuroleptic drug by combining serotonin (5HT2) and dopamine (D2) receptor antagonist; structurally related ...

CAS 118457-16-2 (-)-Nebivolol

(-)-Nebivolol
(CAS: 118457-16-2)

This active molecular is a β-adrenergic receptor antagonist. Levonebivolol is an enantiomer of Nebivolol which is a β1 receptor blocker with nitric oxide-potent...

CAS 67346-49-0 (R,R)-Formoterol

(R,R)-Formoterol
(CAS: 67346-49-0)

(R,R)-Formoterol is a long acting beta-adrenoceptor agonist acts as a novel highly β2-selective adrenergic agonist and holds promise as a β2-agonist that could ...

CAS 85700-55-6 Scopine HCl

Scopine HCl
(CAS: 85700-55-6)

Scopine HCl is the hydrochloride of Scopine, which is the metabolite of anisodine, which is a α1-adrenergic receptor agonist and used in the treatment of acute ...

CAS 23256-50-0 Guanabenz Acetate

Guanabenz Acetate
(CAS: 23256-50-0)

Guanabenz Acetate is an selective agonist of α2a-adrenergic receptor, α2b-adrenergic receptor and α2c-adrenergic receptor with pEC50 of 8.25, 7.01 and ~5, respe...

CAS 57262-94-9 Setiptiline

Setiptiline
(CAS: 57262-94-9)

Setiptiline is is a serotonin receptor antagonist acts as a noradrenergic and specific serotonergic antidepressant.

MK-0634 dihydrochloride
(CAS: 211031-81-1)

MK-0634, also called as L-796568, is an β3 adrenergic receptor agonist that was progressed into clinical studies for the treatment of obesity in the early 2000s...

Chemical Structure

CAS 104054-27-5 Atipamezole

Quick Inquiry

Verification code

Featured Items